Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
3.67M |
$29.8M |
$8.10 |
Jan 24, 2024 |
By Medicxi Growth I LP |
Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
3.64M |
$29.5M |
$8.10 |
Jan 24, 2024 |
By Medicxi IV LP |
Centessa Pharmaceuticals plc |
10%+ Owner |
Ordinary Shares |
281K |
$2.24M |
$7.96 |
Mar 21, 2022 |
Indirect |
Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
87.3K |
$707K |
$8.10 |
Jan 24, 2024 |
By Medicxi Growth Co-Invest I LP |
Aura Biosciences, Inc. |
10%+ Owner |
Common Stock |
70.5K |
$539K |
$7.64 |
Nov 2, 2021 |
Indirect |
Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
62K |
$502K |
$8.10 |
Jan 24, 2024 |
By Medicxi Co-Invest IV LP |
RAPT Therapeutics, Inc. |
10%+ Owner |
Common Stock |
22M |
|
|
Dec 27, 2024 |
By Medicxi IV LP |
RAPT Therapeutics, Inc. |
10%+ Owner |
Common Stock |
374K |
|
|
Dec 27, 2024 |
By Medicxi Co-Invest IV LP |
Aura Biosciences, Inc. |
10%+ Owner |
Series D-1 Convertible Preferred Stock |
0 |
|
|
Nov 2, 2021 |
Indirect |
Aura Biosciences, Inc. |
10%+ Owner |
Series D-2 Convertible Preferred Stock |
0 |
|
|
Nov 2, 2021 |
Indirect |
Aura Biosciences, Inc. |
10%+ Owner |
Series E Convertible Preferred Stock |
0 |
|
|
Nov 2, 2021 |
Indirect |
Centessa Pharmaceuticals plc |
10%+ Owner |
Series A Preferred Shares |
0 |
|
$11.00 |
Jun 2, 2021 |
Indirect |